HCC patients with high TMEM100 expressions also had longer disease-free survival time (median survival time, 42.8 vs.24.1 months, p = 0.019; Figure 5F) than those with low TMEM100 expression. Here, TMEM100 is linked to hepatocellular carcinoma.